Aung TH. Proximicin A-C as prospective HER2-positive and negative breast cancer drugs: Molecular docking and in silico ADME modeling. IPS J Mol Dock Sim [Internet]. 2022 May 18 [cited 2024 Jul. 6];1(1):1-11. Available from: https://drugdiscoveryupdate.com/index.php/IJMDS/article/view/9